Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.

Fabian CJ, Nye L, Powers KR, Nydegger JL, Kreutzjans AL, Phillips TA, Metheny T, Winblad O, Zalles CM, Hagan CR, Goodman ML, Gajewski BJ, Koestler DC, Chalise P, Kimler BF.

Cancer Prev Res (Phila). 2019 Oct;12(10):711-720. doi: 10.1158/1940-6207.CAPR-19-0315. Epub 2019 Aug 16.

PMID:
31420361
2.

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.

Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD.

Cancer Prev Res (Phila). 2015 Oct;8(10):912-21. doi: 10.1158/1940-6207.CAPR-14-0335.

3.

Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Fabian CJ, Kimler BF, Zalles CM, Phillips TA, Metheny T, Petroff BK, Havighurst TC, Kim K, Bailey HH, Heckman-Stoddard BM.

Cancer Prev Res (Phila). 2015 Dec;8(12):1146-55. doi: 10.1158/1940-6207.CAPR-15-0109. Epub 2015 Sep 21.

4.

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.

Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD.

Cancer Prev Res (Phila). 2015 Oct;8(10):922-31. doi: 10.1158/1940-6207.CAPR-14-0336. Epub 2015 Aug 14.

5.

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK, Phillips TA, Metheny T, Aversman S, Yeh HW, Zalles CM, Mills GB, Hursting SD.

Breast Cancer Res Treat. 2013 Nov;142(1):119-32. doi: 10.1007/s10549-013-2730-8. Epub 2013 Oct 19.

6.

Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA.

Cancer Prev Res (Phila). 2010 Oct;3(10):1342-50. doi: 10.1158/1940-6207.CAPR-10-0022. Epub 2010 Aug 19.

7.

Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.

Fabian CJ, Kimler BF, Zalles CM, Khan QJ, Mayo MS, Phillips TA, Simonsen M, Metheny T, Petroff BK.

Breast Cancer Res Treat. 2007 Nov;106(1):75-84. Epub 2007 Jan 13.

PMID:
17221152
8.

Optimization of estrogen receptor analysis by immunocytochemistry in random periareolar fine-needle aspiration samples of breast tissue processed as thin-layer preparations.

Petroff BK, Clark JL, Metheny T, Xue Q, Kimler BF, Fabian CJ.

Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):360-4.

PMID:
16932030
9.

Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.

Sharma P, Kimler BF, Warner C, Metheny T, Xue Q, Zalles CM, Fabian CJ.

Breast Cancer Res Treat. 2006 Nov;100(1):71-6. Epub 2006 Jun 22.

PMID:
16791479
10.

Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.

Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ.

Breast Cancer Res Treat. 2006 May;97(2):191-7. Epub 2005 Dec 2.

PMID:
16322885
11.

Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration.

Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):786-9.

Supplemental Content

Loading ...
Support Center